ALCID SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. WRONIA 45 / U2, 00-870 WARSZAWA
TAX ID5272764145
Rate company:
ALCID SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID5272764145
KRS0000608992
Share capital6,000.00 zł
address
UL. WRONIA 45 / U2, 00-870 WARSZAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
5272764145 
REGON
364005403
KRS
0000608992
Legal form
limited liability company
Register Address
UL. WRONIA 45 / U2, 00-870 WARSZAWA
Date of registration in KRS
2016-03-21
Date of commencement of economic activity
2016-03-21
Act signature
RDF/681236/24/360
Pkd codes
72.11.Z - Research and experimental development on biotechnology
47.7 - Retail sale of other goods in specialised stores
47.91.Z - Retail sale via mail order houses or via Internet
47.99.Z - Other retail sale not in stores, stalls or markets
70.22.Z - Business and other management consultancy activities
86.10.Z - Hospital activities
86.21.Z - General medical practice activities
86.22.Z - Specialist medical practice activities
86.90.D - Paramedical activities
86.90.E - Other human health activities notelsewhere classified
Payer VAT status
Active
Vat list bank account(s)
PL11 1160 2202 0000 0003 0730 4172 
EU grants
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2019 | 2020 | 2021 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale  | -0 | -0,1 | -0,2 | -39,3 |
Gross profit (loss) | -0 | 0 | 2,3 | 16 615,2 |
EBITDA | -0 | 0 | 2,3 | 15 399,8 |
Short time liabilities | 0 | 0 | 0,5 | 4222,4 |
Other operating costs | 0 | 0 | 0 | -∞ |
Equity capital | 0 | 0 | 2,4 | 12 748 |
Operating profit (EBIT) | -0 | 0 | 2,3 | 15 399,8 |
Assets | 0 | 0 | 3,1 | 10 118,1 |
Net profit (loss) | -0 | 0 | 2,3 | 16 734,7 |
Cash | 0 | 0 | 1,1 | 7808,4 |
Net income from sale | 0 | 0 | 0 | 367 |
Liabilities and provisions for liabilities | 0 | 0 | 0,8 | 6136,3 |
Working assets | 0 | 0 | 1,2 | 3787,2 |
Other income costs | 0 | 0,1 | 2,5 | 1888,7 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -80,7 | 75,7 | 99,2 | 23,5 |
Equity capital to total assets | 9,5 | 60,2 | 75,7 | 15,5 |
Gross profit margin | 175,4 | 6278 | 6102,6 | |
EBITDA Margin | 189,1 | 6277,1 | 6088 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 538 | 4979 | 4441 |
Current financial liquidity indicator | 36.3527946472168 | 2.5779874324798584 | 2.3183810710906982 | -0,3 |
Net dept to EBITDA | 16.293750762939453 | -0.918670654296875 | -0.3645372986793518 | 0,5 |
Financial statements
01-01-2021 - 31-12-2021
Resolution on profit distribution or loss coverage
Download pdf01-01-2021 - 31-12-2021
Resolution or decision approving the annual financial statements
Download pdf01-01-2021 - 31-12-2021
Activity report
Download pdf01-01-2021 - 31-12-2021
Annual financial report
Download xml01-01-2021 - 31-12-2021
Annual financial report
Download pdfShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Julia Staszewska
Lublin
IK.Yniks
Ивацевичи
Molecular Biotech Mateusz Gielata
Warszawa
LIFESPAN MOLECULES SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
BIELANY WROCŁAWSKIE